HPK1-IN-4 (comp 22) is a HPK1 (MAPK41) inhibitor (IC 50 of 0.061 nM) as preclinical immunotherapy tool compound.
性状
Solid
IC50 & Target[1][2]
IC50: 0.061 nM (HPK1).
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Brandon A Vara, et al. Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. ACS Med Chem Lett. 2021 Mar 19;12(4):653-661.
溶解度数据
In Vitro: DMSO : 100 mg/mL (230.15 mM; ultrasonic and adjust pH to 4 with HCl)配制储备液